Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.335
-0.095 (-2.77%)
At close: Apr 28, 2026, 4:00 PM EDT
3.260
-0.075 (-2.25%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Indaptus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7 | 5 | 10 | 15 | 12 | 47 | |
| Market Cap Growth | 5.54% | -49.63% | -31.58% | 21.38% | -73.92% | - | |
| Enterprise Value | -1 | -1 | 3 | -1 | -16 | 5 | |
| Last Close Price | 3.26 | 2.91 | 23.58 | 49.28 | 40.60 | 159.60 | |
| PB Ratio | 2.25 | 1.62 | 2.57 | 1.22 | 0.50 | 1.30 | |
| P/TBV Ratio | 2.33 | 1.62 | 2.57 | 1.22 | 0.50 | 1.30 | |
| Debt / Equity Ratio | - | - | 0.02 | 0.01 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -2.70 | -2.70 | -1.45 | -1.09 | -1.07 | -1.08 | |
| Net Debt / EBITDA Ratio | 0.43 | 0.43 | 0.37 | 0.81 | 1.77 | 5.04 | |
| Net Debt / FCF Ratio | 0.57 | 0.57 | 0.46 | 0.98 | 2.02 | 3.45 | |
| Quick Ratio | 1.38 | 1.38 | 1.71 | 4.82 | 7.70 | 8.50 | |
| Current Ratio | 1.51 | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 | |
| Return on Equity (ROE) | -587.59% | -587.59% | -187.53% | -84.04% | -47.32% | -43.25% | |
| Return on Assets (ROA) | -148.91% | -148.91% | -86.28% | -47.63% | -27.15% | -22.81% | |
| Return on Capital Employed (ROCE) | -629.30% | -629.30% | -389.50% | -134.80% | -60.50% | -21.50% | |
| Earnings Yield | -285.21% | -409.13% | -148.48% | -104.31% | -117.58% | -16.51% | |
| FCF Yield | -202.78% | -290.89% | -121.81% | -90.66% | -107.36% | -24.18% | |
| Buyback Yield / Dilution | -189.14% | -189.14% | -11.36% | -1.68% | -101.98% | -110.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.